Statement Of Sen. Patrick Leahy
(D-Vt.),
Chairman, Senate Judiciary Committee,
Hearing On “Regulatory Preemption:
Are Federal Agencies Usurping Congressional And State Authority?”
September 12, 2007


Today the Committee focuses on a little-known abuse of Executive
authority that threatens devastating consequences for American
consumers. Diana Levine was a successful musician in Vermont. She and
her husband performed and recorded children’s music. A few years ago,
she sought medical treatment at a local clinic for nausea and was
injected with an antihistamine. A subsequent infection resulted in
gangrene and, tragically, Diana had to have her arm amputated.
She filed a common law negligence claim at her local courthouse
against the drug’s manufacturer. A jury awarded her $2.4 million in
economic damages and $5 million in non-economic damages for her
life-altering injuries. The drug company defendant appealed. The Vermont
Supreme Court upheld the verdict and judgment upon review.
This tragic case demonstrates how our civil justice system can work.
It also reveals a practice by this Administration to usurp laws through
federal regulations at the expense of consumers. In this case, the drug
company has not accepted the jury findings and decisions of the Vermont
courts. Instead, it is seeking review from the United States Supreme
Court because it argues that federal regulation of the drug’s label
should prevent even the filing of the suit for these injuries.
In this case, the Vermont Supreme Court held that the FDA labeling
rules create only minimum requirements, and that the rules are not
intended to and do not immunize drug companies from liability. I agree
with the Vermont Supreme Court. But I fear that some on the United
States Supreme Court will follow the lead of the Bush Administration and
try to throw Diana out of court -- just as it did Lilly Ledbetter last
year in a terribly cramped legal opinion written by Justice Alito that
prevented redress for employment discrimination.
Diana’s story illustrates how an obscure legal theory called “implied
preemption” is being invoked to shield corporations from culpability and
prevent injured Americans from obtaining redress for their injuries.
Today’s hearing will examine the Bush Administration’s efforts to
assist corporations in this effort and override State laws that protect
Americans. Just yesterday, a judge appointed by this President struck
down a New York City law requiring fast food supposedly conflicted with
federal regulations. Ironically, President Bush once told a group of
governors that the role of the federal government is “not to impose its
will on states and local communities . . . it’s to empower the states
and people and local communities to be able to realize the vast
potential of this country.” That rhetoric rings hollow when the record
shows clearly his Administration’s attempt to grant corporate defendants
blanket civil immunity by aggressively preempting State law in the
course of issuing administrative regulations.
In addition to concerns about the Administration’s actions
threatening principles of federalism, Senator Specter and I joined to
voice our concern about how the Administration’s efforts in this regard
violate powers assigned to Congress. On November 17, 2005, we wrote to
the National Highway Transportation Safety Administration about a
proposed agency rule on “roof crush standards” that sought to preempt
numerous State laws, and ultimately weaken consumer protections for
Americans. Senator Specter and I pointed out in our letter that it
appeared the federal agency was plainly acting beyond the authority
granted to it by Congress in the Transportation Equity Act.
Unfortunately, the federal agency’s response did nothing to address our
questions about its authority to override State laws that may compensate
motorists critically injured in car accidents. Those roof crush
regulations are just one example of at least a dozen issued by the
Consumer Product Safety Commission, the Department of Homeland Security,
the Federal Drug Administration and other federal agencies that are
being used to shield drug and other product manufacturers from liability
without congressional action.
The Administration’s concerted effort to thwart effective consumer
protection and to remove the incentive to improve safety beyond the
minimum standards set by regulatory agencies reminds me of its
politicizing of the Justice Department. Just as we have witnessed
improper political considerations undermine our federal law enforcement
agency for partisan gain, we are now witnessing agency rulemaking turned
into a mechanism to immunize powerful corporations at the expense of
ordinary Americans. Rather than issuing regulations based on facts and
science to benefit the American people, the process has apparently been
hijacked. The intended result of this politically-motivated version of
rulemaking not only slams the local courthouse door shut on injured
victims but it prevents State law, State regulators and State courts
from protecting their citizens.
Our nation’s civil justice system serves not only to compensate those
who have been injured by misconduct but to deter future misconduct. For
hundreds of years that system has provided an effective incentive for
manufacturers to improve safety. That is now being threatened by this
aggressive legal theory. As several of today’s witnesses suggest, when
this Administration could not get Congress to legislate its
anti-consumer agenda, it acted unilaterally through its executive
agencies.
Principles of federalism and the separation of powers are crucial to
our constitutional democracy. When one branch begins to encroach upon
the constitutional responsibilities of another, this should concern not
just members of Congress, but all Americans. When this Administration
attempts to override the efforts of State authorities to provide
meaningful health and safety and consumer protections, all Americans are
more vulnerable. I am glad to have a distinguished panel of witnesses
today to shed some light on this important issue.
# # # # #